ÜbersichtsarbeitOpen access
Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation
Biotherapy · 1993
DOI: 10.1007/bf01877422 ↗At a glance
Übersichtsarbeit in Biotherapy, 1993. Written by B Trijzelaar. Institution: Strategic Biotech International, Zeist, The Netherlands. Cited 11 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
MeSH terms (MEDLINE)
AnimalsBiotechnologyEuropean UnionGuidelines as TopicHumansQuality ControlReproducibility of ResultsViruses
Authors and institutions
- Strategic Biotech International, Zeist, The Netherlands.
Cite
APA
Trijzelaar, B. (1993). Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. https://doi.org/10.1007/bf01877422
Vancouver
Trijzelaar B. Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. 1993. doi:10.1007/bf01877422
BibTeX
@article{Trijzelaar1993,
author = {Trijzelaar, B},
title = {Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation},
journal = {Biotherapy},
year = {1993},
doi = {10.1007/bf01877422}
}
EUVIMED